Entera Bio (ENTX) Non Operating Income (2019 - 2026)
Entera Bio (ENTX) posted quarterly Non Operating Income of $34000.0 for Q1 2026, up 950.0% year-on-year from $3238.1 in Q1 2025, and up 30.77% on a QoQ basis from $26000.0 in Q4 2025.
Entera Bio (ENTX) Non Operating Income (2019 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Non Operating Income for 8 consecutive years, with $34000.0 the latest figure, recorded in Q1 2026.
- Quarterly Non Operating Income rose 950.0% year-over-year to $34000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $128000.0 (up 1322.22% YoY) and the FY2025 annual result came in at $90000.0, up 55.17% from the prior year.
- Non Operating Income grew to $34000.0 in Q1 2026 per ENTX's latest filing, from $26000.0 in the prior quarter.
- Over the last five years, Non Operating Income for ENTX reached as high as $60000.0 in Q2 2022 and fell as low as -$32000.0 in Q4 2023.
- A 5-year average of $18500.0 and a median of $21000.0 in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income tumbled 146.15% — and 2026, when it surged 950.0%.
- Year by year, Non Operating Income stood at -$13000.0 in 2022, then sank by 146.15% to -$32000.0 in 2023, then soared by 78.12% to -$7000.0 in 2024, then jumped by 471.43% to $26000.0 in 2025, then soared by 30.77% to $34000.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $34000.0, $26000.0, and $56000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -8.59 Mn |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | -32,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Jun 30, 2022 | 60,000.00 |
| Mar 31, 2022 | 44,000.00 |
| Dec 31, 2021 | -27,000.00 |
| Sep 30, 2021 | -7,000.00 |
| Jun 30, 2021 | -24,000.00 |
| Mar 31, 2021 | 29,000.00 |